M. Lepainteur
- Infectious Diseases top 10%
- Molecular Medicine top 5%
- Molecular Biology
- Applied Microbiology and Biotechnology top 5%
- Epidemiology
- Co-authors
- Florence Doucet‐PopulaireVincent JarlierJean‐Winoc DecousserChristine LawrenceCatherine DuportOlivier RomainS. FournierGuilhem Royer
- Topics
- Antibiotic Resistance in Bacteria (5 papers)Antibiotic Use and Resistance (4 papers)Antimicrobial Resistance in Staphylococcus (4 papers)
- Journals
- Journal of Clinical MicrobiologyAntimicrobial Agents and ChemotherapyClinical Microbiology and Infection
- Partner nations
- FranceNetherlandsItaly
In The Last Decade
M. Lepainteur
14 papers receiving 283 citations
Peers
Comparison fields: 5 of 51
- Infectious Diseases 134
- Molecular Medicine 129
- Molecular Biology 90
- Applied Microbiology and Biotechnology 60
- Epidemiology 60
Countries citing papers authored by M. Lepainteur
This map shows the geographic impact of M. Lepainteur's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Lepainteur with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Lepainteur more than expected).
Fields of papers citing papers by M. Lepainteur
This network shows the impact of papers produced by M. Lepainteur. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Lepainteur. The network helps show where M. Lepainteur may publish in the future.
Co-authorship network of co-authors of M. Lepainteur
This figure shows the co-authorship network connecting the top 25 collaborators of M. Lepainteur. A scholar is included among the top collaborators of M. Lepainteur based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M. Lepainteur. M. Lepainteur is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 10 | |
| 2 | 9 | |
| 3 | 10 | |
| 4 | 2 | |
| 5 | 23 | |
| 6 | 66 | |
| 7 | 3 | |
| 8 | 8 | |
| 9 | 17 | |
| 10 | 21 | |
| 11 | 42 | |
| 12 | 13 | |
| 13 | 46 | |
| 14 | 20 |
About M. Lepainteur
M. Lepainteur is a scholar working on Applied Microbiology and Biotechnology, Molecular Medicine and Critical Care and Intensive Care Medicine, having authored 14 papers that have together received 290 indexed citations. Recurring topics across this work include Antibiotic Resistance in Bacteria (5 papers), Antibiotic Use and Resistance (4 papers) and Antimicrobial Resistance in Staphylococcus (4 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (60 citations), Molecular Medicine (129 citations) and Clinical Biochemistry (59 citations). M. Lepainteur has collaborated with scholars based in France, Netherlands and Italy. Frequent co-authors include Florence Doucet‐Populaire, Vincent Jarlier, Jean‐Winoc Decousser, Christine Lawrence, Catherine Duport, Olivier Romain, S. Fournier, Guilhem Royer, C Richard and C. Brun‐Buisson. Their work appears in journals such as Journal of Clinical Microbiology, Antimicrobial Agents and Chemotherapy and Clinical Microbiology and Infection.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.